Anticoagulants Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1065093
  • May 2021
  • Pharmaceuticals
  • 122 Pages
The Anticoagulants Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Bristol-Myers Squibb Company, GlaxoSmithKline plc., Pfizer Inc., Sanofi, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, DAIICHI SANKYO COMPANY, LIMITED, Portola Pharmaceuticals, Inc., Novartis AG
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Anticoagulants market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Anticoagulants market is expected to attain Pre COVID-19 levels by mid-2022.

Anticoagulants Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Anticoagulants market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Anticoagulants Market Competitive and Premeditated Analysis
In the Anticoagulants report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Anticoagulants research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Anticoagulants Market:
The Anticoagulants market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Bristol-Myers Squibb Company, GlaxoSmithKline plc., Pfizer Inc., Sanofi, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, DAIICHI SANKYO COMPANY, LIMITED, Portola Pharmaceuticals, Inc., Novartis AG

The Anticoagulants market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Anticoagulants Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Anticoagulants market:
by Drug Class
Novel Oral Anticoagulants
NOACs
Heparin & Low-Molecular-Weight Heparin
LMWH
Vitamin K Antagonist
Others
Route Of Administration
Oral anticoagulant
Injectable anticoagulant
Application
Atrial fibrillation & Heart Attack
Stroke
Deep Vein Thrombosis
DVT
Pulmonary Embolism
PE
Others
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regional Analysis of the Anticoagulants market:
The Anticoagulants market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Anticoagulants report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Anticoagulants market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Anticoagulants market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Anticoagulants market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Anticoagulants market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Anticoagulants market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Anticoagulants market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Anticoagulants market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Anticoagulants market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Sanofi
  • Aspen Holdings
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • DAIICHI SANKYO COMPANY, LIMITED
  • Portola Pharmaceuticals, Inc.
  • Novartis AG
  • Novel Oral Anticoagulants
  • NOACs
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Anticoagulants Market Snapshot
          2.1.1. Global Anticoagulants Market By Drug Class,2019
               2.1.1.1.Novel Oral Anticoagulants
               2.1.1.2.NOACs
          2.1.2. Global Anticoagulants Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Online Pharmacies
          2.1.3. Global Anticoagulants Market By End-use,2019
          2.1.4. Global Anticoagulants Market By Geography,2019

3. Global Anticoagulants Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Anticoagulants Market Size (US$), By Drug Class, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Drug Class, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Drug Class, 2020
     4.2. Global Anticoagulants Market Size (US$), By Drug Class, 2018 – 2028

5. Global Anticoagulants Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Anticoagulants Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Anticoagulants Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Anticoagulants Market Size (US$), By End-use, 2018 – 2028

7. Global Anticoagulants Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Anticoagulants Market Analysis, 2018 – 2028 
          7.2.1. North America Anticoagulants Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Anticoagulants Market Size (US$), By Drug Class, 2018 – 2028
          7.2.3. North America Anticoagulants Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Anticoagulants Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Anticoagulants Market Analysis, 2018 – 2028 
          7.3.1.  Europe Anticoagulants Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Anticoagulants Market Size (US$), By Drug Class, 2018 – 2028
          7.3.3. Europe Anticoagulants Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Anticoagulants Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Anticoagulants Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Anticoagulants Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Anticoagulants Market Size (US$), By Drug Class, 2018 – 2028
          7.4.3. Asia Pacific Anticoagulants Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Anticoagulants Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Anticoagulants Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Anticoagulants Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Anticoagulants Market Size (US$), By Drug Class, 2018 – 2028
          7.5.3. Latin America Anticoagulants Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Anticoagulants Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Anticoagulants Market Analysis, 2018 – 2028 
          7.6.1.  MEA Anticoagulants Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Anticoagulants Market Size (US$), By Drug Class, 2018 – 2028
          7.6.3. MEA Anticoagulants Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Anticoagulants Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Anticoagulants Providers
        8.4.1 Bristol-Myers Squibb Company
                8.4.1.1 Business Description
                8.4.1.2 Bristol-Myers Squibb Company Geographic Operations
                8.4.1.3 Bristol-Myers Squibb Company Financial Information
                8.4.1.4 Bristol-Myers Squibb Company Product Positions/Portfolio
                8.4.1.5 Bristol-Myers Squibb Company Key Developments
        8.4.2 GlaxoSmithKline plc.
                8.4.2.1 Business Description
                8.4.2.2 GlaxoSmithKline plc. Geographic Operations
                8.4.2.3 GlaxoSmithKline plc. Financial Information
                8.4.2.4 GlaxoSmithKline plc. Product Positions/Portfolio
                8.4.2.5 GlaxoSmithKline plc. Key Developments
        8.4.3 Pfizer Inc.
                8.4.3.1 Business Description
                8.4.3.2 Pfizer Inc. Geographic Operations
                8.4.3.3 Pfizer Inc. Financial Information
                8.4.3.4 Pfizer Inc. Product Positions/Portfolio
                8.4.3.5 Pfizer Inc. Key Developments
        8.4.4 Sanofi
                8.4.4.1 Business Description
                8.4.4.2 Sanofi Geographic Operations
                8.4.4.3 Sanofi Financial Information
                8.4.4.4 Sanofi Product Positions/Portfolio
                8.4.4.5 Sanofi Key Developments
        8.4.5 Aspen Holdings
                8.4.5.1 Business Description
                8.4.5.2 Aspen Holdings Geographic Operations
                8.4.5.3 Aspen Holdings Financial Information
                8.4.5.4 Aspen Holdings Product Positions/Portfolio
                8.4.5.5 Aspen Holdings Key Developments
        8.4.6 Bayer AG
                8.4.6.1 Business Description
                8.4.6.2 Bayer AG Geographic Operations
                8.4.6.3 Bayer AG Financial Information
                8.4.6.4 Bayer AG Product Positions/Portfolio
                8.4.6.5 Bayer AG Key Developments
        8.4.7 Boehringer Ingelheim International GmbH
                8.4.7.1 Business Description
                8.4.7.2 Boehringer Ingelheim International GmbH Geographic Operations
                8.4.7.3 Boehringer Ingelheim International GmbH Financial Information
                8.4.7.4 Boehringer Ingelheim International GmbH Product Positions/Portfolio
                8.4.7.5 Boehringer Ingelheim International GmbH Key Developments
        8.4.8 DAIICHI SANKYO COMPANY, LIMITED
                8.4.8.1 Business Description
                8.4.8.2 DAIICHI SANKYO COMPANY, LIMITED Geographic Operations
                8.4.8.3 DAIICHI SANKYO COMPANY, LIMITED Financial Information
                8.4.8.4 DAIICHI SANKYO COMPANY, LIMITED Product Positions/Portfolio
                8.4.8.5 DAIICHI SANKYO COMPANY, LIMITED Key Developments
        8.4.9 Portola Pharmaceuticals, Inc.
                8.4.9.1 Business Description
                8.4.9.2 Portola Pharmaceuticals, Inc. Geographic Operations
                8.4.9.3 Portola Pharmaceuticals, Inc. Financial Information
                8.4.9.4 Portola Pharmaceuticals, Inc. Product Positions/Portfolio
                8.4.9.5 Portola Pharmaceuticals, Inc. Key Developments
        8.4.10 Novartis AG
                8.4.10.1 Business Description
                8.4.10.2 Novartis AG Geographic Operations
                8.4.10.3 Novartis AG Financial Information
                8.4.10.4 Novartis AG Product Positions/Portfolio
                8.4.10.5 Novartis AG Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Anticoagulants Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Anticoagulants Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Anticoagulants Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Anticoagulants Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Anticoagulants Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Anticoagulants Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Anticoagulants Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Anticoagulants Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Anticoagulants Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Anticoagulants Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Anticoagulants Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Anticoagulants Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Anticoagulants Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Anticoagulants Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Anticoagulants Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Anticoagulants Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Anticoagulants: Market Segmentation 
FIG. 2 Global Anticoagulants Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Anticoagulants Market, By Drug Class, 2019 (US$ Mn) 
FIG. 5 Global Anticoagulants Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Anticoagulants Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Anticoagulants Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Anticoagulants Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Anticoagulants Providers, 2019
FIG. 11 Global Anticoagulants Market Revenue Contribution, By Drug Class, 2019 & 2028 (Value %) 
FIG. 12 Global Anticoagulants Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Anticoagulants Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Anticoagulants Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Anticoagulants Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Anticoagulants Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Anticoagulants Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Anticoagulants Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Anticoagulants market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Anticoagulants Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Anticoagulants Market Value, By Segment1, 2018 – 2028
TABLE  North America Anticoagulants Market Value, By Segment2, 2018 – 2028
TABLE  North America Anticoagulants Market Value, By Country, 2018 – 2028
TABLE  Europe Anticoagulants Market Value, By Segment1, 2018 – 2028
TABLE  Europe Anticoagulants Market Value, By Segment2, 2018 – 2028
TABLE  Europe Anticoagulants Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Anticoagulants Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Anticoagulants Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Anticoagulants Market Value, By Country, 2018 – 2028
TABLE  Latin America Anticoagulants Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Anticoagulants Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Anticoagulants Market Value, By Country, 2018 – 2028
TABLE  MEA Anticoagulants Market Value, By Segment1, 2018 – 2028
TABLE  MEA Anticoagulants Market Value, By Segment2, 2018 – 2028
TABLE  MEA Anticoagulants Market Value, By Country, 2018 – 2028
TABLE  Bristol-Myers Squibb Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Aspen Holdings: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boehringer Ingelheim International GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  DAIICHI SANKYO COMPANY, LIMITED: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Portola Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Anticoagulants Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Anticoagulants Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Anticoagulants Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Anticoagulants Market, By Geography, 2019 (US$ Mn)
FIG.  Global Anticoagulants Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Anticoagulants Providers, 2016
FIG.  Global Anticoagulants Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global NOACs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Anticoagulants Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Anticoagulants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Anticoagulants Market Value, 2018 – 2028, (US$ Mn)